Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.

Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its profit view.

Abbott Laboratories (ABT) is currently at $99.59, up $10.32 or 11.56%